The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
Open accessAbstract
BACKGROUND: Meta-analyses have identified serum levels of brain-derived neurotrophic factor (BDNF) as a potential biomarker for major depressive disorder (MDD). However, at the time, commercially available human ELISA kits are unable to distinguish between proBDNF (precursor of BDNF) and mature BDNF because of limited BDNF antibody specificity. In this study, we examined whether serum levels of proBDNF, mature BDNF, and matrix metalloproteinase-9 (MMP-9), which converts proBDNF to mature BDNF, are altered in patients with MDD. METHODOLOGY/PRINCIPAL FINDINGS: Sixty-nine patients with MDD and 78 age- and gender-matched healthy subjects were enrolled. Patients were evaluated using 17 items on the Structured Interview Guide for the Hamilton Depression Rating Scale. Cognitive impairment was evaluated using the CogState battery. Serum levels of proBDNF, mature BDNF, and MMP-9 were measured using ELISA kits. Serum levels of mature BDNF in patients with MDD were significantly lower than those of normal controls. In contrast, there was no difference in the serum levels of proBDNF and MMP-9 between patients and normal controls. While neither proBDNF nor mature BDNF serum levels was associated with clinical variables, there were significant correlations between MMP-9 serum levels and the severity of depression, quality of life scores, and social function scores in patients. CONCLUSIONS/SIGNIFICANCE: These findings suggest that mature BDNF may serve as a biomarker for MDD, and that MMP-9 may play a role in the pathophysiology of MDD. Further studies using larger sample sizes will be needed to investigate these results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 7×
“However, in this study, we found no correlation between mature BDNF levels and the severity of depression in patients with MDD. Patients enrolled in this study had moderate, but not severe symptoms of depression (SIGH-D score; 0–24) compared with our previous report [7].”
MethodInfluentialNestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Diagnostic and Statistical Manual of Mental Disorders
Sciacca, F., Knipe, H., & Sharma, R. (2020) · Radiopaedia.org · doi:10.53347/rid-80880 · Cited by 2,361
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Keefe, R. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2003.09.011 · Cited by 1,573
Ostwald, P. F. (1960) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1960.14.4.817 · Cited by 1,357
The yin and yang of neurotrophin action
Lu, B., Pang, P. T., & Woo, N. H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1726 · Cited by 1,356
Sen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232
New insights into BDNF function in depression and anxiety
Martinowich, K., Manji, H., & Lu, B. (2007) · Nature Neuroscience · doi:10.1038/nn1971 · Cited by 1,221
Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S.-I., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00181-1 · Cited by 1,151 · cited 5×
“Patients enrolled in this study had moderate, but not severe symptoms of depression (SIGH-D score; 0–24) compared with our previous report [7].”
BackgroundResultInfluentialSelf-citationBrunoni, A. R., Lopes, M., & Fregni, F. (2008) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009309 · Cited by 972
Altar, C. A. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01309-7 · Cited by 534
Critical Role of Brain-Derived Neurotrophic Factor in Mood Disorders
Hashimoto, K., Shimizu, E., & Iyo, M. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.02.003 · Cited by 522
Self-citationNeurocognitive impairment in drug-free patients with major depressive disorder
Porter, R. J., Gallagher, P., Thompson, J. M., & Young, A. H. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.3.214 · Cited by 519
Cognitive impairment in major depression
Marazziti, D., Consoli, G., Picchetti, M., Carlini, M., & Faravelli, L. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.046 · Cited by 448
Molendijk, M. L., Bus, B. A. A., Spinhoven, P., Penninx, B. W. J. H., Kenis, G., Prickaerts, J., Voshaar, R. O., & Elzinga, B. M. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.98 · Cited by 437
Serum and plasma BDNF levels in major depression: A replication study and meta-analyses
Bocchio-Chiavetto, L., Bagnardi, V., Zanardini, R., Molteni, R., Gabriela Nielsen, M., Placentino, A., Giovannini, C., Rillosi, L., Ventriglia, M., Riva, M. A., et al. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622971003611319 · Cited by 435
Cognitive impairment in the remitted state of unipolar depressive disorder: A systematic review
Hasselbalch, B. J., Knorr, U., & Kessing, L. V. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.11.011 · Cited by 406
Hashimoto, K. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02113.x · Cited by 388
Self-citationMatrix metalloproteinases in brain development and remodeling: Synaptic functions and targets
Ethell, I. M., & Ethell, D. W. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21273 · Cited by 378 · cited 2×
“MMP-9 plays a key role in synaptic plasticity of the brain, and acts by converting proBDNF to mature BDNF, which in turn results in TrkB activation [15,16].”
BackgroundDomenici, E., Willé, D. R., Tozzi, F., Prokopenko, I., Miller, S., McKeown, A., Brittain, C., Rujescu, D., Giegling, I., Turck, C. W., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009166 · Cited by 347
Lu, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00538-5 · Cited by 267
Activation of the Trk Signaling Pathway by Extracellular Zinc
Hwang, J. J., Park, M.-H., Choi, S.-Y., & Koh, J.-Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m403172200 · Cited by 206
Pietrzak, R. H., Olver, J., Norman, T., Piskulic, D., Maruff, P., & Snyder, P. J. (2009) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390802592458 · Cited by 201
Mizoguchi, H., Nakade, J., Tachibana, M., Ibi, D., Someya, E., Koike, H., Kamei, H., Nabeshima, T., Itohara, S., Takuma, K., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3118-11.2011 · Cited by 199
Assessment of social functioning in depression
Bosc, M. (2000) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(00)90133-0 · Cited by 168
Cognition and depression: the effects of fluvoxamine, a sigma‐1 receptor agonist, reconsidered
Hindmarch, I., & Hashimoto, K. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1106 · Cited by 121
Self-citationBDNF variant linked to anxiety‐related behaviors
Hashimoto, K. (2007) · BioEssays · doi:10.1002/bies.20534 · Cited by 98
Self-citationJohannsen, A., Rydmark, I., Söder, B., & Åsberg, M. (2007) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2007.00980.x · Cited by 96
RYBAKOWSKI, J. K. (2009) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2009/904836 · Cited by 85
Yoshida, T. (2012) · The Open Clinical Chemistry Journal · doi:10.2174/1874241601205010007 · Cited by 63
Self-citationYoshida, T., Suga, M., Arima, K., Muranaka, Y., Tanaka, T., Eguchi, S., Lin, C., Yoshida, S., Ishikawa, M., Higuchi, Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020469 · Cited by 46
Self-citationUeda, N., Suda, A., Nakagawa, M., Nakano, H., Umene‐Nakano, W., Ikenouchi, A., Hori, H., Yoshimura, R., & Nakamura, J. (2011) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2011.02274.x · Cited by 33
A BDNF Val66Met Polymorphism and Ketamine-induced Rapid Antidepressant Action
Hashimoto, K. (2012) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2012.10.1.59 · Cited by 20
Self-citation
Cited by
Molendijk, M. L., Spinhoven, P., Polak, M., Bus, B. A. A., Penninx, B. W. J. H., & Elzinga, B. M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.105 · Cited by 702
Brain-Derived Neurotrophic Factor in Alzheimer’s Disease and Its Pharmaceutical Potential
Gao, L., Zhang, Y., Sterling, K., & Song, W. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00279-0 · Cited by 606
Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant Action
Castrén, E., & Monteggia, L. M. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.05.008 · Cited by 540
Phillips, C. (2017) · Neural Plasticity · doi:10.1155/2017/7260130 · Cited by 450
MMP‐9 in translation: from molecule to brain physiology, pathology, and therapy
Vafadari, B., Salamian, A., & Kaczmarek, L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13415 · Cited by 382
Metadata
- Authors
- Yoshida, T., Ishikawa, M., Niitsu, T., Nakazato, M., Watanabe, H., Shiraishi, T., Shiina, A., Hashimoto, T., Kanahara, N., Hasegawa, T., Enohara, M., Kimura, A., Iyo, M., & Hashimoto, K.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-08-03
- Volume
- 7
- Issue
- 8
- Pages
- e42676
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2041444771
- Cited by
- 277
- References
- 34
- FWCI
- 15.07
- Type
- journal article
- Language
- en
- Update notices
- correction (2013-02-25)
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.